Novo Nordisk says completes haemophilia drug trial

COPENHAGEN, May 17 (Reuters) - Denmark's Novo Nordisk , the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a haemophilia drug, N9-GP.

---

Novo Nordisk A/S Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!BAGSVAERD, DENMARK--(Marketwired - May 17, 2013) - Novo Nordisk today announced thecompletion of para…

---

Novo Nordisk A/S – Share Repurchase Programme

BAGSVAERD, DENMARK--(Marketwired - May 13, 2013) - Company Announcement No 36 2013: http://hugin.info/2013/R/1701189/561614.pdf…

---

Novo Nordisk A/S Invests $69 Million in Plant, Creating 50 New Production/Engineering Jobs

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Novo Nordisk says the $69 investment in its Danish plant will convert capacity ready for its new GLP-1 analog…

---